Studies have demonstrated that ZYIL1 is highly potent and can suppress inflammation caused by NLRP3 inflammasome activation
The products are slated to be manufactured at the Ankleshwar facility and is expected to start contributing meaningfully to the revenue from FY25
Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year's list
This development is a strategic part of the company's commitment to bolstering its position in the advanced pharmaceutical intermediates segment
The product will be manufactured at Lupin's Pithampur facility in India
Expands patient reach to remotest towns by furthering investment in GoApptiv
The company makes its maiden entry into Azerbaijan’s pharmaceutical market
Pantoprazole Sodium Delayed-Release Tablets are indicated for short-term treatment of Erosive Esophagitis associated with GERD
Announces changes in the commercial organization to incorporate Seagen and improve focus, speed and execution
The CVMP recommends the product for approval for the treatment and persistent killing of fleas
Subscribe To Our Newsletter & Stay Updated
